General Anesthesia Drugs Market Size, Forecast, and Y-o-Y Analysis-2017-2025

Google+ Pinterest LinkedIn Tumblr +

General anesthesia is a therapeutically induced condition of unconsciousness; that is, loss of protective reflexes, which results from the use of one or multiple general anesthetic agents. The drug is administered to allow performing the medical procedures which are unbearably painful for the patient. A range of medicines can be administered, the overall aim of which is to ensure unconsciousness, analgesia, and loss of reflexes of the ANS or autonomic nervous system. In some cases, general anesthetic drugs are used for paralyzing the skeletal muscles.

Request Sample Copy of the Business Report:

Presently, there is a lack of consistency of technique in the general anesthetic field. Anesthesiologists have a preference for using one or a mixture of drugs. This choice depends upon the choice and experience of the physician or surgeon and the physiological state in which the patient is in. General anesthesia drugs are utilized in a number of surgeries. The general anesthesia drugs market is likely to be boosted by the rising number of surgeries including orthopedic, general surgeries, cardiac, and others throughout the globe. Moreover, advancements in the anesthesia drug delivery methods, such as jet injection, inhalation and computer controlled anesthesia delivery systems will further encourage the general anesthesia drugs industry. Nevertheless, lack of proper health care facilities especially in the underdeveloped countries as well as in remote areas, presence of few anesthetists and certified nurse per capita of population are likely to inhibit the growth of the general anesthesia drugs market.

High growth in the number of surgeries and rise in geriatric population will drive the overall general anesthesia drugs market

The increasing volume of surgical procedures across the globe is likely to drive the overall growth of the anesthesia drugs market in the forecast period. Anesthesia is used during different surgical procedures which are conducted to manage various diseases including gastrointestinal diseases, cardiovascular diseases, spinal abnormalities, urological disorders, orthopedic deformities, and brain tumors. The significant growth in the number of surgeries, especially in the European countries will help in the growth of the general anesthesia drugs market in this region. For example, the amount of laparoscopic colostomy surgeries tripled in Spain and doubled in Slovenia between 2008 and 2014.  Different types of surgeries performed in various ASCs or ambulatory surgical centers include hernia procedure, cervix and uterus removal, transurethral excision, lens and cataract, and hysterectomy. The increase in geriatric population as well as the growth in the number of surgeries will fuel the growth of the general anesthesia drugs market in the near future.

By geography, North America held the maximum share of general anesthesia drugs market in 2016 and is projected to continue its dominance during the forecast period. The rising demand for propofol is one of the primary causes for this dominance of the North America market, especially the U.S. Moreover, the rising focus by a significant number of manufacturers to explore new routes of administration such as topical and oral will boost adoption of anesthetic drugs in the overall market. The rising demand for anesthesia in labor patients is anticipated to propel the market growth as well. According to a report by Centers for Disease Control and Prevention (CDC), around 3,984,502 deliveries including caesarean and vaginal took place in 2016 in the U.S.

To get detailed table of content (ToC), please click:

The major players operating in the global general anesthesia drugs market are Baxter, B. Braun, AbbVie, Aspen, Fresenius Kabi, Arbor Pharmaceuticals, Air Liquide, Avera Pharmaceuticals, GSK, Eisai, Jiangsu HengRui Medicine, Lannett Company, Johnson & Johnson, Merck, Mydent International, Nuvo Pharmaceuticals, Novalar Pharma, Paion UK, Primex Pharmaceuticals, Pfizer,St. Renatus, The Medicines Company, and Takeda.


About Author

Is a technology enthusiast, who has amassed a wide range of experience in the industry at a very young age. His extensive background of computer software and programming and proclivity to be up-to-date with the latest of technology upgrades and launches, helps him deliver the most intriguing and trending tech news. Contact Author

Comments are closed.